financetom
Business
financetom
/
Business
/
Best Buy lifts annual profit forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Best Buy lifts annual profit forecast
Aug 29, 2024 4:33 AM

Aug 29 (Reuters) - Best Buy ( BBY ) raised its annual

profit forecast on Thursday as tighter controls on costs help

the electronics retailer offset the impact from steeper

discounts and promotions across categories.

The company expects adjusted earnings per share for fiscal

year 2025 to be $6.10 to $6.35, compared with the earlier

forecast of $5.75 to $6.20.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palabra AI Acquires Talo and Launches Suite of Real-Time Multilingual Communication Products
Palabra AI Acquires Talo and Launches Suite of Real-Time Multilingual Communication Products
Nov 10, 2025
LONDON--(BUSINESS WIRE)-- Palabra AI, the company behind sub-second speech-to-speech translation, today announced the acquisition of Talo and the launch of a new user-facing product that brings Palabra’s technology directly to everyday conversations. The acquisition marks Palabra’s expansion from infrastructure into a full product ecosystem that brings its core technology directly to everyday communication. With the integration of Talo’s team and...
Marriott International Terminates Licensing Deal With Sonder
Marriott International Terminates Licensing Deal With Sonder
Nov 10, 2025
04:52 AM EST, 11/10/2025 (MT Newswires) -- Marriott International ( MAR ) said late Sunday it terminated its licensing deal with Sonder ( SOND ) due to the latter's default. As a result of the termination, Sonder ( SOND ) is no longer affiliated with Marriott Bonvoy, and its properties are not available for new bookings on Marriott's ( MAR...
Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy
Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy
Nov 10, 2025
04:45 AM EST, 11/10/2025 (MT Newswires) -- Innate Pharma ( IPHA ) said Monday that the US Food and Drug Administration completed a review of its confirmatory phase 3 protocol for lacutamab as a possible treatment for cutaneous T-cell lymphomas, clearing the trial to move forward. The phase 3 trial is designed to show the efficacy of lacutamab in patients...
Italian SMR firm Newcleo looking to build 20 reactors in US
Italian SMR firm Newcleo looking to build 20 reactors in US
Nov 10, 2025
PARIS, Nov 10 (Reuters) - Italian small-modular-reactor startup Newcleo is considering developing 20 reactors worth an estimated 16 billion euros ($19 billion) in the United States, not in Britain as previously planned, as recent policy changes opened opportunity for investment, CEO Stefano Buono told Reuters. U.S. President Donald Trump signed an executive order in May to boost domestic nuclear production...
Copyright 2023-2026 - www.financetom.com All Rights Reserved